Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease
- PMID: 16786254
- DOI: 10.1007/s10545-006-0312-1
Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease
Abstract
Copper-histidine is the treatment of choice in Menkes disease but bears the potential risk of copper overload and induced liver cirrhosis. We report normal copper concentrations of liver tissue over an 8-year treatment period with copper-histidine.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources